Potential benefits of anticoagulant doses of low molecular weight heparin in COVID-19: An observational retrospective study. Emerg Care J [Internet]. 2021 Sep. 21 [cited 2026 May 12];17(3). Available from: https://www.pagepressjournals.org/ecj/article/view/9795